Evidence map›Paper›PMID 34080973›Full record

ArticleeLife2021

Tight nanoscale clustering of Fcγ receptors using DNA origami promotes phagocytosis.

Nadja Kern, Rui Dong, Shawn M Douglas, Ronald D Vale, Meghan A Morrissey

Open access · goldAbstract readVideo-Audio Media
In one paragraph

Article in eLife, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
5.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 67 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. EPY001, a Novel Monoclonal Antibody AgainstInternational journal of molecular sciences · 2025
    Article
  10. Review
  11. Clustering of Membrane Receptors: Insights from DNA Origami-Based Approaches.Small (Weinheim an der Bergstrasse, Germany) · 2025
    Review
  12. Phagocytosis at a glance.Journal of cell science · 2025
    Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Bottom-up synthetic immunology.Nature nanotechnology · 2024
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Nadja KernDepartment of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, United States.ORCID https://orcid.org/0000-0002-1313-5890
Rui DongDepartment of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, United States.ORCID http://orcid.org/0000-0002-9118-3636
Shawn M DouglasDepartment of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, United States.ORCID https://orcid.org/0000-0001-5398-9041
Ronald D ValeDepartment of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, United States.ORCID https://orcid.org/0000-0003-3460-2758
Meghan A MorrisseyDepartment of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, United States.ORCID https://orcid.org/0000-0002-0531-4864
Howard Hughes Medical Institute · USUniversity of California, San Francisco · USUniversity of California, Santa Barbara · US

Funding

STRUCTURAL BIOLOGY TRAINING PROGRAMT32GM008284 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KORTEMME, TANJA · 1988 to 2022
$10.1M
Collaboration between Phosphatidylserine receptorsF32GM120990 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MORRISSEY, MEGHAN A · 2016 to 2019
$177k
Howard Hughes Medical InstituteNIGMS NIH HHS F32 GM120990NIGMS NIH HHS T32 GM008284
6 · The paper itself

Abstract

Macrophages destroy pathogens and diseased cells through Fcγ receptor (FcγR)-driven phagocytosis of antibody-opsonized targets. Phagocytosis requires activation of multiple FcγRs, but the mechanism controlling the threshold for response is unclear. We developed a DNA origami-based engulfment system that allows precise nanoscale control of the number and spacing of ligands. When the number of ligands remains constant, reducing ligand spacing from 17.5 nm to 7 nm potently enhances engulfment, primarily by increasing efficiency of the engulfment-initiation process. Tighter ligand clustering increases receptor phosphorylation, as well as proximal downstream signals. Increasing the number of signaling domains recruited to a single ligand-receptor complex was not sufficient to recapitulate this effect, indicating that clustering of multiple receptors is required. Our results suggest that macrophages use information about local ligand densities to make critical engulfment decisions, which has implications for the mechanism of antibody-mediated phagocytosis and the design of immunotherapies.

Indexed as

Macrophage ActivationNanotechnologyPhagocytosisAnimalsDNAHEK293 CellsHumansKineticsLigandsMacrophagesMiceNucleic Acid ConformationPhosphorylationRAW 264.7 CellsReceptors, Chimeric AntigenReceptors, IgGDNALigandsReceptors, Chimeric AntigenReceptors, IgGAntibodycell biologyDNA origamiFc ReceptorhumanimmunologyimmunotherapyinflammationmousePhagocytosissynthetic biology

Identifiers

PMID34080973
PMCPMC8175083
OpenAlexW3165200359

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.